MedTrace Logo

Gabapentin for Carpal Tunnel Syndrome

NCT00137735 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 150

Last updated 2007-10-31

No results posted yet for this study

Summary

The purpose of this study is to determine whether gabapentin is safe and effective in the treatment of carpal tunnel syndrome (CTS).

Conditions

  • Carpal Tunnel Syndrome

Interventions

DRUG

Gabapentin

300mg tds

OTHER

placebo

tds

Sponsors & Collaborators

  • Pfizer

    collaborator INDUSTRY

  • Chinese University of Hong Kong

    lead OTHER

Principal Investigators

  • Andrew CF Hui, FHKAM · Department of Medicine & Therapeutics, Faculty of Medicine, The Chinese University of Hong Kong

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2003-10-31
Completion
2006-12-31

Countries

  • Hong Kong

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00137735 on ClinicalTrials.gov